← Leaderboards
Oded Regev
New York University
$644,779
Attributed
$644,779
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $242K · FY2022–24$250K$187.5K$125K$62.5K$0
'22
'23
'24
Funding mix
By agency
NIH$644,779 · 1
By mechanism
R21$644,779 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University
Same institution · by research overlap
- Paramjit S Arora$12,984,973
- Oded Regev$2,716,247
Others in their field
Other Rising Stars on “3&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Sandro Da Mesquita · Mayo Clinic Jacksonville$2,250,745
- Wang-Xia Wang · University Of Kentucky$1,975,255
- Nicholas Ashton · Banner Health$1,967,076
- Bryan K Woodruff · Banner Health$1,967,076
Research focus
3&AposFluorescenceAffectAmino AcidsElementsExon SkippingBindingCatalytic RnaCell LineCell ModelCell SeparationAdenosineClustered Regularly Interspaced Short Palindromic RepeatsExhibitsCodon NucleotidesCombinatorialCostCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDesignDisease-Causing MutationDrug Delivery SystemsDuchenne Muscular DystrophyGene Delivery
Grant awards (3)
Readthrough of disease-causing nonsense mutations by targeted selenocysteine recoding$201,709
R21 · FY2024 · EB · contact PI
Readthrough of disease-causing nonsense mutations by targeted selenocysteine recoding$241,959
R21 · FY2023 · EB · contact PI
Readthrough of disease-causing nonsense mutations by targeted selenocysteine recoding$201,111
R21 · FY2022 · EB · contact PI